News | Artificial Intelligence | January 27, 2023

Blackford and Brainomix Announce AI Partnership for Stroke Care

Strategic partnership increases access to advanced AI-assisted stroke care 

Strategic partnership increases access to advanced AI-assisted stroke care

January 27, 2023 — Blackford, the pioneering strategic imaging AI platform and solutions provider, and Brainomix, the AI-powered medtech solutions company, have announced a strategic partnership to bring Brainomix’s comprehensive e-Stroke solution to the Blackford Platform, making advanced stroke care available to more institutions around the world. 

According to the World Stroke Organization, there are over 12.2 million new strokes each year. In more rural areas, access to advanced imaging may be limited, which can have a negative impact on stroke diagnosis and treatment. Brainomix’s e-Stroke AI tools can generate real-time interpretation of more widely available non-contrast CT exams, expanding access to life-saving stroke treatments. 

"Timely diagnosis and treatment of stroke should not be limited to urban areas and comprehensive stroke centers,” said Blackford Founder and CEO Ben Panter. “Adding Brainomix’s AI-powered e-Stroke to the Blackford Platform allows more institutions around the world to accelerate transfer and treatment times and expand access to critical endovascular therapy for their patients.” 

Brainomix’s AI-powered e-Stroke tools can utilize images from non-contrast or contrast enhanced CT exams to provide physicians fast, effective, and accurate analysis of images that expedite treatment decisions. Combined with the e-Stroke Mobile app, physicians can quickly and securely access, review, and share patient images and data to optimize workflow and facilitate faster transfer and treatment decisions. 

“We are very excited to launch this partnership with Blackford – a company that has firmly established itself as a leading provider of tailored best-in-class medical imaging and AI-powered solutions that deliver clinical value, with an extensive customer base and a highly regarded focus on technical excellence,” said Dr Michalis Papadakis, CEO & co-founder at Brainomix. “With our e-Stroke platform, we believe that we have the opportunity to work together to provide physicians with the most comprehensive stroke AI imaging solution, shown to optimize networks and ultimately improve patient outcomes.” 

For more information: www.brainomix.com


Related Content

News | Stroke

Nov. 10, 2025 — Sentante, a med-tech robotics company, has successfully demonstrated a first-of-a-kind remote stroke ...

Home November 10, 2025
Home
News | Stroke

Oct. 22, 2025 — Basking Biosciences, a clinical-stage biopharmaceutical company developing the first reversible ...

Home October 22, 2025
Home
News | Stroke

Oct. 21, 2025 — At the seventeenth edition of the World Stroke Congress in Barcelona, Siemens Healthineers will present ...

Home October 21, 2025
Home
News | Stroke

Aug. 19, 2025 — Openwater, an open-source medical technology company delivering portable, hospital-grade diagnostic and ...

Home August 21, 2025
Home
News | Stroke

Aug. 19, 2025 — In a move to advance stroke care and accelerate critical decision-making, Tift Regional Medical Center ...

Home August 19, 2025
Home
News | Stroke

July 9, 2025 — InspireMD, Inc., developer of the CGuard Prime carotid stent system for the prevention of stroke ...

Home July 09, 2025
Home
News | Stroke

May 28, 2025 — Siemens Healthineers has introduced the first mobile stroke unit (MSU) featuring the Somatom On.site head ...

Home May 28, 2025
Home
News | Stroke

May 21, 2025 — RapidAI recently announced new study findings that show RapidAI’s clinically deep algorithms deliver ...

Home May 21, 2025
Home
News | Stroke

April 17, 2025 — Adults younger than 50 years of age had more than double the risk of having a stroke from migraine or ...

Home April 17, 2025
Home
News | Stroke

On April 9, 2025, the world’s first multisector advocacy movement dedicated to stroke — the Global Stroke Action ...

Home April 15, 2025
Home
Subscribe Now